Wainer Zoli
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Oncology top 1%
- Cancer Cells and Metastasis
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 95
- Cancer Treatment and Pharmacology 25
- Colorectal Cancer Treatments and Studies 24
- Cancer Cells and Metastasis 14
- HER2/EGFR in Cancer Research 13
-
- Cancer Genomics and Diagnostics 16
- Co-authors
- Dino AmadoriPaola UliviAnna TeseiFrancesco� FabbriDaniele CalistriRosella SilvestriniGiovanni Luca FrassinetiD. Amadori
- Journals
- Journal of Cellular Physiology (8 papers)Journal of Translational Medicine (8 papers)International Journal of Molecular Sciences (5 papers)Breast Cancer Research and Treatment (5 papers)The International Journal of Biological Markers (4 papers)
- Partner nations
- ItalyUnited StatesNetherlands
In The Last Decade
Wainer Zoli
157 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 120
- Cancer Research 1.1k
- Oncology 1.7k
- Pathology and Forensic Medicine 461
- Pulmonary and Respiratory Medicine 828
- Molecular Biology 1.4k
Countries citing papers authored by Wainer Zoli
This map shows the geographic impact of Wainer Zoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wainer Zoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wainer Zoli more than expected).
Fields of papers citing papers by Wainer Zoli
This network shows the impact of papers produced by Wainer Zoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wainer Zoli. The network helps show where Wainer Zoli may publish in the future.
Co-authors
The 25 scholars most cited alongside Wainer Zoli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 31 | |
| 2 | 2014 | 10 | |
| 3 | 2013 | 12 | |
| 4 | 2013 | 65 | |
| 5 | 2013 | 15 | |
| 6 | 2013 | 32 | |
| 7 | 2012 | 28 | |
| 8 | 2011 | 21 | |
| 9 | 2009 | 12 | |
| 10 | Different mechanisms involved in the activity of BAY 43-9006 (Sorafenib) in human pancreatic cancer cell lines | 2008 | 1 |
| 11 | 2008 | 23 | |
| 12 | 2008 | 21 | |
| 13 | 2007 | 22 | |
| 14 | 2006 | 11 | |
| 15 | 2005 | 28 | |
| 16 | 2003 | 10 | |
| 17 | 2002 | 10 | |
| 18 | 1998 | 4 | |
| 19 | 1998 | 12 | |
| 20 | A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer. | 1996 | 35 |
About Wainer Zoli
Wainer Zoli is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Toxicology and Pathology and Forensic Medicine, having authored 160 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (25 papers), Colorectal Cancer Treatments and Studies (24 papers), Lung Cancer Treatments and Mutations (18 papers), Cancer Genomics and Diagnostics (16 papers), Genetic factors in colorectal cancer (16 papers), Cancer therapeutics and mechanisms (16 papers), Cancer Cells and Metastasis (14 papers) and HER2/EGFR in Cancer Research (13 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.7k citations), Pathology and Forensic Medicine (461 citations), Pulmonary and Respiratory Medicine (828 citations) and Molecular Biology (1.4k citations). Wainer Zoli has collaborated with scholars based in Italy, United States and Netherlands. Frequent co-authors include Dino Amadori, Paola Ulivi, Anna Tesei, Francesco� Fabbri, Daniele Calistri, Rosella Silvestrini, Giovanni Luca Frassineti, D. Amadori, Silvia Carloni and Luca Ricotti. Their work appears in journals such as Journal of Cellular Physiology, Journal of Translational Medicine, International Journal of Molecular Sciences, Breast Cancer Research and Treatment and The International Journal of Biological Markers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.